<DOC>
	<DOCNO>NCT00807937</DOCNO>
	<brief_summary>The purpose research study determine whether AstraZeneca 's drug AZD7325 safe effective treatment generalize anxiety disorder .</brief_summary>
	<brief_title>Proof Concept Patients With Generalized Anxiety Disorder ( GAD ) AZD7325</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Signed informed consent studyrelated procedure start . The patient previously diagnose Generalized Anxiety Disorder . The patient HADSA ( anxiety ) score â‰¥10 screen randomization . Patient lifetime history schizophrenia psychotic disorder Patient history seizure seizure disorder . Patient pregnant breast feeding . Patient receive electroconvulsive treatment ( ECT ) past .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>GAD</keyword>
	<keyword>Anxiety</keyword>
</DOC>